Eric Huckins discusses enhancing specialty pharmacy programs in health systems by addressing challenges like 340B, payer access, and accreditation. He emphasizes the importance of strategic partnerships, biosimilars, and technology in improving patient care and fostering growth.
In his latest article highlighted in the ACHE-WI newsletter, our Vice President of Business Development, Eric Huckins, shares actionable insights we’ve used to help health systems unlock their specialty pharmacy’s full potential.
Arkansas’s Act 624 to ban PBMs from owning pharmacies is being framed as a win for independent pharmacies. But what happens when legislation targets ownership structure instead of business practices?
Amanda, Manager of Experiential Learning and Chair of the accredited Oncology Center of Excellence, has been a specialty pharmacist at Lumicera since 2023. For the past two years, she has also been a caregiver for a cancer patient…her son.
Eric Huckins, our Vice President of Business Development, sat down with Todd Eury of the Pharmacy Podcast Network during Asembia to share his insights on specialty pharmacy.
This July, Lumicera Specialty Pharmacy will be competing as a team in the Arthritis Foundation’s annual Jingle-in-July run, walk, or bike race!
This week, our very own Dr. Ben Heiser was a guest on the Pharmacy Podcast Network! In his interview, Ben shares just how special specialty pharmacy really is—especially when it’s done right.
We are thrilled to announce our partnership with Costco! With this, we will be able to grow cost-plus specialty pharmacy in the marketplace, while continuing to provide unmatched patient support!
Our recent survey highlights several important issues patients face today, including an unclear understanding of their medication costs.
The leading cost-plus specialty pharmacy will offer direct access to ustekinumab-aekn, reducing plan sponsor costs by up to $336,000 per patient per year and generating $120 million annualized client savings
